9 results
10-K
2013 FY
RVNC
Revance Therapeutics Inc
28 Mar 14
Annual report
12:00am
corporate governance, board oversight and transactional experience. Our board of directors believes that such experience allows Mr. Eastman to make
424B4
t8mrjmcf3q3irg1e
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
va09udg
31 Dec 13
IPO registration
12:00am
DRS
pj9gcz aa700
19 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next